(Q44048848)

29 November 2017

title

Self-selected women with polycystic ovary syndrome are reproductively and metabolically abnormal and undertreated (English)

1 reference

polycystic ovary syndrome

29 November 2017

main subject

1 reference

1 reference

1

1 reference

29 November 2017

Margrit Urbanek

2

0 references

author name string

Allen R Kunselman

series ordinal

3

1 reference

29 November 2017

Benjamin E Leiby

series ordinal

4

1 reference

29 November 2017

Andrea Dunaif

series ordinal

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

29 November 2017

published in

Fertility and Sterility

1 reference

29 November 2017

volume

78

1 reference

29 November 2017

issue

1

1 reference

29 November 2017

page(s)

51-57

1 reference

A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS". what are we to call it?!

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Polycystic ovaries--a common finding in normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

The prevalence of polycystic ovaries on ultrasound scanning in a population of randomly selected women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Adiposity, fat distribution, and cardiovascular risk

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Polycystic ovary syndrome and hyperprolactinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Screening for 21-hydroxylase-deficient nonclassic adrenal hyperplasia among hyperandrogenic women: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Diagnosis of polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Endometrial cancer associated with polycystic ovaries in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

CLINICAL AND BIOCHEMICAL FEATURES OF POLYCYSTIC OVARIAN DISEASE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

Diagnostic and treatment characteristics of polycystic ovary syndrome: descriptive measurements of patient perception and awareness from 657 confidential self-reports

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2802%2903153-9

10.1016/S0015-0282(02)03153-9

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference